Re: Chicharros USA - bolsa internacional
La news anterior la hecho subir 3, 40 a casi 2 horas de sesion, asi es de volatil, sigole viendo recorrido en el medio plazo dado que debe liberar resultados en Q1/2016
-------
Cowen analyst Ritu Baral reiterated an Outperform rating on shares of Mast Therapeutics, as the company is on track to announce top-line data in the first-quarter of 2016 for vepoloxamer in sickle cell pain crisis
http://www.smarteranalyst.com/2015/10/12/analysts-reiterate-bullish-stance-on-mast-therapeutics-inc-mstx-and-tg-therapeutics-inc-tgtx/